SpiroChem is actively supporting programs tackling “difficult-to-drug” targets using peptides, peptidomimetics, and macrocycles.
With an extensive internal toolbox of unnatural amino acids and linkers, a robust synthetic platform, and deep expertise in transforming peptidic signatures into drug-like molecules, SpiroChem is the ideal partner to accelerate your drug discovery projects.
